MedTrace Logo

Start Time Optimization of Biologics in Polyarticular JIA

NCT02593006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-02-05

Study results available
· View outcomes & findings →

Summary

STOP-JIA is a PCORI funded prospective observational study which compared the clinical effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis \& Rheumatology Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to begin biologic medications to achieve the optimal clinical and patient reported outcomes. Because the CARRA Registry will be used for data collection, all patients will be enrolled in the CARRA Registry. The standard of care treatments are chosen by the treating physician and patient/caregiver and are not randomized.

Conditions

  • Polyarticular Juvenile Rheumatoid Arthritis
  • Arthritis, Juvenile Idiopathic

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Childhood Arthritis and Rheumatology Research Alliance

    collaborator OTHER

  • Duke Clinical Research Institute

    collaborator OTHER

  • Seattle Children's Hospital

    collaborator OTHER

  • Children's Hospital of Philadelphia

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • University Health Network, Toronto

    collaborator OTHER

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Yukiko Kimura, MD · Hackensack Meridian Health

  • Sarah Ringold, MD · Seattle Children's Hospital

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593006 on ClinicalTrials.gov